Because we detected LAT1 expression in all NHL samples examined and found a positive correlation between LAT1 expression and lymphoma grade, we hypothesized that inhibition of LAT1 might suppress the growth of lymphoma cells, and inhibitors of LAT1 can be novel therapeutics for NHL. The gene discussed is LAT; the disease is non-Hodgkin lymphoma.